SunWay Biotech Co

SunWay Biotech Co ROIC

The Return on Invested Capital (ROIC) of SunWay Biotech Co (1271.TWO) as of Nov 20, 2026 is 2.77 %. In the previous year, Return on Invested Capital (ROIC) was 3.38 % — a change of -18.07% (lower).

ROIC

2.77 %

YoY

-18.07%

Last updated:

Return on Invested Capital (ROIC) of SunWay Biotech Co is 2025 2.77 % . Return on Invested Capital (ROIC) of SunWay Biotech Co was 2024 3.38 % . It decreases by -18.07% lower compared to the previous year.

The SunWay Biotech Co ROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROIC
Date
ROIC
Jan 1, 2019
12.81 TWD
Jan 1, 2020
26.24 TWD
Jan 1, 2021
29.90 TWD
Jan 1, 2022
8.36 TWD
Jan 1, 2023
1.32 TWD
Jan 1, 2024
3.38 TWD
Jan 1, 2025
2.77 TWD
The SunWay Biotech Co ROIC history
YEARROICYoY
2.77 %-18.07%
3.38 %+156.41%
1.32 %-84.25%
8.36 %-72.05%
29.90 %+13.97%
26.24 %+104.82%
12.81 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SunWay Biotech Co Stock analysis

What does SunWay Biotech Co do? SunWay Biotech Co., Ltd. generates revenue through the research, development, manufacture, and sale of red yeast health food products. The company's main products include Lactobacillus paracasei subsp. paracasei NTU 101 and Monascus purpureus NTU 568, which target digestive health, bacterial ecology regulation, immunity, and allergy management. These products are sold in both domestic and overseas markets, catering to consumers seeking natural health solutions. The firm focuses on health food segments where digestive and immune support are key consumer needs. The company's product portfolio emphasizes specific strains like Lactobacillus paracasei subsp. paracasei NTU 101 and Monascus purpureus NTU 568, which are marketed for their functional benefits in digestion and immune regulation. These health foods are distributed across domestic and international channels, targeting health-conscious consumers who prioritize natural remedies. SunWay Biotech leverages its research-driven approach to position these products in the health food market. SunWay Biotech Co., Ltd. operates within the health food industry, focusing on products that address digestive and immune health through natural ingredients. Its offerings are designed to improve bacterial ecology in the digestive tract and regulate immunity and allergies, appealing to a segment of consumers interested in preventive health solutions. The company's domestic and overseas market strategy ensures broad reach for its specialized health food products. SunWay Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SunWay Biotech Co stock

Return on Invested Capital (ROIC) of SunWay Biotech Co is 2.77 % in 2025.

Return on Invested Capital (ROIC) of SunWay Biotech Co changed from 3.38 % to 2.77 %, representing a -18.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Invested Capital (ROIC) SunWay Biotech Co since 2006 – with annual values, charts, and detailed analysis.

ROIC measures how effectively a company uses its invested capital to generate profits. A ROIC above the cost of capital creates shareholder value.

ROIC = NOPAT / Invested Capital

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Invested Capital (ROIC)'s SunWay Biotech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Invested Capital (ROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Invested Capital (ROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — SunWay Biotech Co

All Key Metrics — SunWay Biotech Co